G Bruno, P Zaccari, G Rocco, G Scalese… - World journal of …, 2019 - ncbi.nlm.nih.gov
Proton pump inhibitors (PPIs) are common medications within the practice of gastroenterology. These drugs, which act through the irreversible inhibition of the …
R Fossmark, TC Martinsen, HL Waldum - International journal of …, 2019 - mdpi.com
Proton pump inhibitors (PPIs) have been increasingly used over the last decades and there are concerns about overuse and the numerous reported side-effects. It is uncertain whether …
Alzheimer's disease (AD) is the most common type of dementia, mainly encompassing cognitive decline in subjects aged≥ 65 years. Further, AD is characterized by selective …
Y Nassar, S Richter - Journal of bone metabolism, 2018 - synapse.koreamed.org
Background This study's objective was to evaluate the association between proton-pump inhibitor (PPI) use and bone fracture incidence and bone mineral density (BMD) by meta …
ER de Santiago, CT Sanchez-Vegazo… - Endoscopy …, 2021 - thieme-connect.com
Background and study aims Antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA) are new endoscopic procedures for patients with gastroesophageal reflux …
A Corsonello, F Lattanzio, S Bustacchini… - Current drug …, 2018 - ingentaconnect.com
Objective: We aimed at summarizing current evidence about mechanisms for potentially harmful effects of Proton Pump Inhibitors (PPIs). Methods: A Pubmed search was performed …
Dokumenty przygotowane przez CPG nie zdejmują jednak w jakikolwiek sposób z pracowników opieki zdrowotnej indywidualnej odpowiedzialności za podejmowanie …
L Fisher, A Fisher - Clinical drug investigation, 2017 - Springer
This narrative review summarises the benefits, risks and appropriate use of acid- suppressing drugs (ASDs), proton pump inhibitors and histamine-2 receptor antagonists …